Through this vital new partnership, the Society for Integrative Oncology and ONCOLOGY seek to make integrative medicine part of standard clinical oncology practice, and to help physicians and patients make informed decisions about complementary and alternative medicine to maximize benefits and minimize harms.
In this interview we discuss health disparities in cancer care, how redesigning cancer clinical trials can address some of these disparities, and goals for the “next generation” of cancer health disparities research.
This article reviews the mechanisms of sexual dysfunction that occur after breast cancer, offers some practical guidance on how to discuss this effectively with patients, and reviews the data and recommendations for optimizing management.
In this review, we focus on the treatment of well-differentiated early and metastatic PNETs, emphasizing current controversies, recent advances in therapy, and the multidisciplinary approach required for optimal treatment.
Serial PSA testing with early salvage radiotherapy is a viable option in most high-risk men.
The data for adjuvant radiotherapy remain strong.